Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 3, 2024
Cancer
metastasis
remains
a
critical
factor
contributing
to
the
current
limitations
in
cancer
treatment.
Photothermal
immunotherapy
has
emerged
as
safe
and
potent
therapeutic
approach,
demonstrating
capability
suppress
tumor
growth
metastasis.
While
researchers
have
extensively
investigated
various
structural
modifications
enhance
photothermal
conversion
performance,
influence
of
molecular
configuration
received
comparatively
limited
attention.
In
this
study,
we
synthesized
two
isomers,
CZTBT
LVTBT,
which
possessed
distinct
configurations.
characterized
by
flatter
configuration,
exhibited
an
extended
absorption
wavelength
higher
molar
extinction
coefficient.
Its
excited
state
facilitated
stronger
rotation
for
non-radiative
transitions,
leading
high
efficiency
(PCE)
36.3
%.
When
combined
with
R848,
LVTBT@R848
nanoparticles
(NPs)-mediated
functioned
situ
vaccine,
promoting
maturation
dendritic
cells
(DCs),
T
cell
infiltration,
differentiation
natural
killer
(NK)
memory
cells,
thereby
activating
strong
immune
response.
Consequently,
it
significantly
inhibited
both
primary
distant
tumors,
while
also
limiting
lung
summary,
study
proposed
configuration-mediated
transition
strategy
efficient
immunotherapy,
advancing
frontiers
organic
agents
(OPTAs)
design
synthesis.
Angewandte Chemie,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 3, 2024
Abstract
Cancer
metastasis
remains
a
critical
factor
contributing
to
the
current
limitations
in
cancer
treatment.
Photothermal
immunotherapy
has
emerged
as
safe
and
potent
therapeutic
approach,
demonstrating
capability
suppress
tumor
growth
metastasis.
While
researchers
have
extensively
investigated
various
structural
modifications
enhance
photothermal
conversion
performance,
influence
of
molecular
configuration
received
comparatively
limited
attention.
In
this
study,
we
synthesized
two
isomers,
CZTBT
LVTBT,
which
possessed
distinct
configurations.
characterized
by
flatter
configuration,
exhibited
an
extended
absorption
wavelength
higher
molar
extinction
coefficient.
Its
excited
state
facilitated
stronger
rotation
for
non‐radiative
transitions,
leading
high
efficiency
(PCE)
36.3
%.
When
combined
with
R848,
LVTBT@R848
nanoparticles
(NPs)‐mediated
functioned
situ
vaccine,
promoting
maturation
dendritic
cells
(DCs),
T
cell
infiltration,
differentiation
natural
killer
(NK)
memory
cells,
thereby
activating
strong
immune
response.
Consequently,
it
significantly
inhibited
both
primary
distant
tumors,
while
also
limiting
lung
summary,
study
proposed
configuration‐mediated
transition
strategy
efficient
immunotherapy,
advancing
frontiers
organic
agents
(OPTAs)
design
synthesis.
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 3, 2024
Cancer
metastasis
remains
a
critical
factor
contributing
to
the
current
limitations
in
cancer
treatment.
Photothermal
immunotherapy
has
emerged
as
safe
and
potent
therapeutic
approach,
demonstrating
capability
suppress
tumor
growth
metastasis.
While
researchers
have
extensively
investigated
various
structural
modifications
enhance
photothermal
conversion
performance,
influence
of
molecular
configuration
received
comparatively
limited
attention.
In
this
study,
we
synthesized
two
isomers,
CZTBT
LVTBT,
which
possessed
distinct
configurations.
characterized
by
flatter
configuration,
exhibited
an
extended
absorption
wavelength
higher
molar
extinction
coefficient.
Its
excited
state
facilitated
stronger
rotation
for
non-radiative
transitions,
leading
high
efficiency
(PCE)
36.3
%.
When
combined
with
R848,
LVTBT@R848
nanoparticles
(NPs)-mediated
functioned
situ
vaccine,
promoting
maturation
dendritic
cells
(DCs),
T
cell
infiltration,
differentiation
natural
killer
(NK)
memory
cells,
thereby
activating
strong
immune
response.
Consequently,
it
significantly
inhibited
both
primary
distant
tumors,
while
also
limiting
lung
summary,
study
proposed
configuration-mediated
transition
strategy
efficient
immunotherapy,
advancing
frontiers
organic
agents
(OPTAs)
design
synthesis.